EUVIMEDEUVIMED entdecken
Open Access

Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy

Gohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, Aaron Seo, Lewis F Nasr, Hind Rafei, Melody R Becnel, Krina K Patel, Hans C Lee, Gregory P Kaufman, Mahmoud M Gaballa, Jing Christine Ye und 9 weitere

Clinical Lymphoma Myeloma and Leukemia · 2025

DOI: 10.1016/j.clml.2024.11.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025. Verfasst von Gohar S Manzar und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Musculoskeletal Imaging, The Universi…. Hauptthemen laut MEDLINE: Multiple Myeloma, Central Nervous System Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The prognosis of multiple myeloma involving the central nervous system (CNS-MM) is poor. We report outcomes of CNS-MM treated with CNS-directed radiation therapy (RT). METHODS: We retrospectively reviewed patients with CNS-MM treated with CNS-directed RT from 2015 to 2024. CNS-MM was defined as having radiographic leptomeningeal or parenchymal disease, and/or pathologic CSF involvement. Complete response (CR) constituted having no atypical cells in CSF or resolution of radiographic disease. Otherwise, patients were categorized with partial response (PR) based on imaging, or stable disease (SD). The Kaplan-Meier method was used to estimate survival. RESULTS: Of 45 patients with CNS-MM, 28 (62.2%) had high-risk disease. Median overall survival (OS) was 3.7 months (range: 0.4-52.2) postdiagnosis of CNS-MM. Most patients (n = 22, 48.9%) underwent craniospinal irradiation; 9 received whole brain RT (20%), and the others received focal brain or spine RT. The median dose was 20 Gy (2-30 Gy) in 10 fractions (1-15). Due to death or discharge to hospice before further follow-up of treatment efficacy (n = 24), only 21 patients (46.7%) were evaluable post-RT with adequate CSF or radiographic follow-up. For these evaluable patients, post-RT CR occurred in 14 patients (66.7%), PR in 5 (23.8%), and SD in 2 (9.5%). For patients with CR after RT, the median OS was 7.3 months (3-52.2) from CNS-MM diagnosis. Focal brain CNS-MM associated with improved OS and likelihood of attaining long-term survival with CNS CR. CONCLUSION: Aggressive multimodality therapy including RT may induce durable CNS control in a small subset of patients with CNS-MM, a high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaCentral Nervous System NeoplasmsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultTreatment OutcomeAged, 80 and overPrognosis

Stichwörter der Autor:innen

CSICraniospinal irradiationExtramedullary multiple myelomaLeptomeningeal diseaseRT

Autor:innen und Institutionen

  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Ho…

Förderung

  • NCI NIH HHS

Zitieren

APA

Manzar, G. S., Dudzinski, S. O., Yoder, A. K., Seo, A., Nasr, L. F., Rafei, H., Becnel, M. R., Patel, K. K., Lee, H. C., Kaufman, G. P., Gaballa, M. M., Ye, J. C., Saini, N., Thomas, S. K., Amini, B., Orlowski, R. Z., Dabaja, B. S., Pinnix, C. C., Gunther, J. R., …, & Fang, P. Q. (2025). Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.11.010

Vancouver

Manzar GS, Dudzinski SO, Yoder AK, Seo A, Nasr LF, Rafei H, et al. Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy. Clinical Lymphoma Myeloma and Leukemia. 2025. doi:10.1016/j.clml.2024.11.010

BibTeX
@article{Manzar2025,
  author = {Manzar, Gohar S and Dudzinski, Stephanie O and Yoder, Alison K and Seo, Aaron and Nasr, Lewis F and Rafei, Hind and Becnel, Melody R and Patel, Krina K and Lee, Hans C and Kaufman, Gregory P and Gaballa, Mahmoud M and Ye, Jing Christine and Saini, Neeraj and Thomas, Sheeba K and Amini, Behrang and Orlowski, Robert Z and Dabaja, Bouthaina S and Pinnix, Chelsea C and Gunther, Jillian R and Wu, Susan Y and Fang, Penny Q},
  title = {Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2025},
  doi = {10.1016/j.clml.2024.11.010}
}
Kostenlos starten →